Sebastian Guth is Executive Vice President and Chief Marketing Officer for Bayer Pharmaceuticals. In addition, he is responsible for the P&L and entire operations of Bayer's global Radiology Business Unit. Mr. Guth is a member of the Pharmaceuticals Executive Committee and Global Pharmaceuticals Development Committee.
Based in Berlin, Germany, Mr. Guth oversees global product strategy, marketing, market access and marketing operations for Bayer’s prescription pharmaceuticals portfolio. Bayer Pharmaceuticals’ portfolio focuses on highly innovative new launches and a broad range of established products for cardiology and women’s healthcare as well as for specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Radiology Business Unit develops and commercializes diagnostic imaging equipment together with the necessary contrast agents.
Before assuming his current role at Bayer Pharmaceuticals in October 2015, Mr. Guth was Chief Marketing Officer for Bayer’s General Medicine Business. Previously he served as President & Chief Executive Officer of Bayer Yakuhin Ltd., Osaka, leading Bayer’s healthcare business in Japan.
Sebastian Guth’s professional career in the pharmaceuticals industry started in 2001 with Schering where he was Special Projects Leader for Asia and the Middle East. This led to his transfer to Schering Singapore Pte. as Managing Director for Malaysia, Singapore, and Vietnam the following year. Returning to Berlin in 2005, Mr. Guth was appointed Head of Strategy and Business Development for Schering’s European business. Following Bayer’s acquisition of Schering in 2006, he acted as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey from 2007, until his transfer to Japan in early 2011.
Born in 1974, Sebastian Guth is married and has three children.